Halma makes medical acquisition

Health and sensor technology business Halma has acquired Swiss-based Medicel for CHF70 million (£46.6 million).


Health and sensor technology business Halma has acquired Swiss-based Medicel for CHF70 million (£46.6 million).

Health and sensor technology business Halma has acquired Swiss-based Medicel for CHF70 million (£46.6 million).

As part of the deal, Halma, which has offices in the UK, also acquires Robutec GmbH, a subsidiary of Medicel.

Medicel designs and supplies injector devices for intra ocular lenses used for cataract surgery.

Andrew Williams, chief executive of Halma comments: ‘Medicel and Robutec further extend our presence in the ophthalmic surgery instrument market which is forecast to see continued growth due to an aging population and increased global access to healthcare.’

Medicel and Robutec will operate as a single company within Halma’s health and analysis sector as part of the Health Optics group of businesses. 

Ellie

Ellie Duncan

Ellie was a features writer for What Investment magazine and our sister publication Business XL from 2010 to 2011, before moving on to the Financial Times.

Related Topics

Healthcare Sector